ROBINS CHAD M bought ADPT
March 4, 2026 · Form 4 insider transaction
ROBINS CHAD M bought 127,813 shares of Adaptive Biotechnologies Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
127,813
Price
$0.00
Total value
N/A
InsiderROBINS CHAD M
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 4, 2026
Filing dateMarch 6, 2026
Shares owned after2,062,060
OwnershipDirect
10b5-1 planNo
AmendedNo